Galderma will present new data on Relfydess (RelabotulinumtoxinA) – the first and only ready-to-use liquid neuromodulator created using PEARL™ Technology, which has now launched in multiple countr......
Turin, 23rd January 2025. Iveco Group N.V. (EXM: IVG) confirmed today that its financial results for the Fourth Quarter and Full Year of 2024 will be presented on Friday, 7th February 2025.
